Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 77 recruiting now early-phase tilt #72 of 28,707 conditions

PTSD: early-phase trial registry

77 of 155 indexed PTSD trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #72 of 28,707 conditions by registered trial count.

155 US clinical trials · 77 currently recruiting · #72 of 28,707 conditions by registered trial count

PTSD: 155 US clinical trials tracked, 77 recruiting.

PTSD is the subject of 155 registered US clinical trials on ClinicalTrials.gov, 77 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 28 of these trials.

Enrollment posture brief

Registry condition ptsd

OPEN 77 | RECR 50% | LATE 10 | EARLY 29 | RANK #72 | SPON 28

Nearest open-share peer: Alzheimer Disease (50% recruiting · 312 trials)

PTSD (this)50%Obstructive Sleep Apnea42%Stress41.8%Insomnia40.8%Influenza17.2%
Open-enrollment share among volume-matched conditions near PTSD

PTSD lists 77 open slots (50% of 155 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PTSD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PTSD is recruiting above its size-band peers.

    77 of 155 indexed trials (49.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates PTSD research.

    VA Office of Research and Development accounts for 28 of 155 trials (18.1%). 88 distinct sponsors appear on at least one study for this condition label.

  3. Typical PTSD enrolment sits around 75 participants.

    Median target enrolment is 75 among the 155 trials that report a genuine target (sentinel values excluded). 89 of those (57.4%) plan for fewer than 100 participants.

  4. PTSD research is mostly interventional.

    143 interventional and 12 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 17Phase 222Phase 35Phase 45

Open and recent trials

155 total, page 3 of 4

COMPLETED NA 171 participants

Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care

VA Office of Research and Development

NCT01710306

COMPLETED 168 participants

Key Dimensions of PTSD and ED

University of California, Los Angeles

NCT03778307

COMPLETED Phase 2 168 participants

Integrated Alcohol Disorder and PTSD Treatment

VA Office of Research and Development

NCT01601067

COMPLETED Phase 2 159 participants

Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions

Tonix Pharmaceuticals

NCT02421679

COMPLETED NA 157 participants

Improving Treatment Outcomes for Suicidal Veterans With PTSD

Ohio State University

NCT04690582

COMPLETED NA 134 participants

Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy

University of Central Florida

NCT04549493

COMPLETED NA 129 participants

Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs

VA Office of Research and Development

NCT01357577

COMPLETED NA 128 participants

Implementation of Prolonged Exposure in the Military

University of Pennsylvania

NCT02982538

COMPLETED NA 112 participants

The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk

Duke University

NCT02736929

COMPLETED Phase 2 108 participants

Women Overcoming and Managing Adversity Now (WOMAN) Study

UConn Health

NCT01324765

COMPLETED Phase 3 101 participants

Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)

VA Office of Research and Development

NCT00108576

COMPLETED NA 98 participants

Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries

Carrick Institute for Graduate Studies

NCT02003352

COMPLETED Phase 3 93 participants

A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD

Tonix Pharmaceuticals

NCT03508700

COMPLETED NA 90 participants

A Non-Pharmacological Method for Enhancing Sleep in PTSD

University of Arizona

NCT02370173

COMPLETED NA 84 participants

Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians

University of New Mexi

NCT02124694

COMPLETED NA 76 participants

Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD

VA Office of Research and Development

NCT02641496

COMPLETED NA 69 participants

PTSD Treatment for Incarcerated Men and Women: NIMH

University of Wisconsin, Madison

NCT05168267

COMPLETED Phase 3 64 participants

Individual PE vs Couples' CBT for Combat-Related Posttraumatic Stress Disorder

Toronto Metropolitan University

NCT02336971

COMPLETED NA 62 participants

Effect of tDCS Timing on Safety Memory in PTSD

Butler Hospital

NCT04152772

COMPLETED NA 60 participants

Pilot Evaluation of AboutFace: Novel Peer Education Resource for Veterans

VA Office of Research and Development

NCT02486692

COMPLETED NA 60 participants

Intensive Care Unit (ICU) Diary Project

Tulane University School of Medicine

NCT04305353

COMPLETED NA 59 participants

Peer-led Trauma Therapy for Re-entry

University of Wisconsin, Madison

NCT06019767

COMPLETED 57 participants

Post-Traumatic Stress Disorder (PTSD) Symptom Study

VA Office of Research and Development

NCT00018798

COMPLETED NA 57 participants

The Treatment of Depression With Yoga and Walking

Boston University

NCT02907476

COMPLETED NA 56 participants

Evaluating Supplementing Residential Substance Use Treatment With Written Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD)

VA Office of Research and Development

NCT05536908

COMPLETED NA 54 participants

Improving Implementation of Evidence Based PTSD Psychotherapy for Veterans in the Community

Veterans Medical Research Foundation

NCT02499432

COMPLETED Phase 2 47 participants

Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder

Baylor College of Medicine

NCT00383786

COMPLETED Phase 2 44 participants

Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence

Medical University of South Carolina

NCT01055171

COMPLETED NA 43 participants

Neural Changes Associated With a Mindfulness-based Intervention for Young Adults With Childhood Maltreatment

Massachusetts General Hospital

NCT02447744

COMPLETED Phase 2 41 participants

Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)

Dennis Charney

NCT00749203

COMPLETED Phase 4 40 participants

Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

Tuscaloosa Research & Education Advancement Corporation

NCT00203463

COMPLETED NA 40 participants

Care Outcomes for Chiropractic Outpatient Veterans

Palmer College of Chiropractic

NCT03254719

COMPLETED 40 participants

PTSD and Risk Behavior in HIV Positive Female Adolescents

University of North Carolina, Chapel Hill

NCT00271882

COMPLETED Phase 2 38 participants

Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

Lykos Therapeutics

NCT03282123

COMPLETED NA 36 participants

Pilot Trial of Mobile Mantram Delivery

VA Office of Research and Development

NCT05998967

COMPLETED NA 35 participants

Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees

University of Michigan

NCT03711266

COMPLETED NA 35 participants

Exercise and Therapeutic Learning Among Women With PTSD

University of Wisconsin, Madison

NCT04113798

COMPLETED NA 34 participants

Evaluation of Effectiveness of a Group Yoga Intervention as Trauma Therapy for Adolescent Girls

Hamilton Health Sciences Corporation

NCT02373358

COMPLETED Early Phase 1 33 participants

Supported Education Pilot

US Department of Veterans Affairs

NCT01073657

COMPLETED Phase 1 30 participants

Doxazosin FOR Ptsd

Baylor College of Medicine

NCT02308202

COMPLETED NA 30 participants

RRT for PTSD Symptoms in Survivors of Sexual Violence

University of Colorado, Denver

NCT04073004

COMPLETED 29 participants

Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)

New York State Psychiatric Institute

NCT02645929

COMPLETED Phase 4 26 participants

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

VA Nebraska Western Iowa Health Care System

NCT01271244

COMPLETED 26 participants

Novel EEG Coherence Biomarkers for PTSD Assessment

VA Office of Research and Development

NCT04209387

COMPLETED Phase 4 25 participants

Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence

Medical University of South Carolina

NCT00330239

COMPLETED NA 23 participants

Synchronized Transcranial Magnetic Stimulation for PTSD

Providence VA Medical Center

NCT02981381

COMPLETED NA 21 participants

Efficacy of a Brief Nightmare Treatment for Veterans

University of Tul

NCT01220401

COMPLETED Phase 1 20 participants

Methylphenidate for Ptsd and Stroke Veterans

VA Office of Research and Development

NCT04885257

COMPLETED NA 20 participants

Clinician-Supported PTSD Coach vs. Self-Managed PTSD Coach

Syracuse VA Medical Center

NCT02400710

COMPLETED Phase 2 16 participants

Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD

Icahn School of Medicine at Mount Sinai

NCT04889664

← Previous Page 3 of 4 Next →

Phase Distribution

PhaseTrial count
Phase 1 7
Phase 2 22
Phase 3 5
Phase 4 5

Named interventions

Most-linked intervention names on PTSD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cognitive Processing Therapy Behavioral
11 trials
Placebo Drug
9 trials
Treatment as Usual Behavioral
3 trials
Ketamine Drug
3 trials
Placebo Other
3 trials
Low Intensity Exercise Behavioral
2 trials
Cognitive Processing Therapy (CPT) Behavioral
2 trials
Exposure Therapy Behavioral
2 trials

US sites by state

Facility locations filed on PTSD trials. A trial with sites in several states counts in each.

California 26 trials
Texas 20 trials
New York 19 trials
Massachusetts 15 trials
South Carolina 14 trials
Florida 13 trials
Wisconsin 10 trials
Washington 10 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PTSD page

155 registered trials, 77 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PTSD condition card totals 155 registered trials; most-linked intervention Cognitive Processing Therapy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.